Omega-3 fish oil supplements could backfire without this key enzyme

Researchers have uncovered a critical factor in the effectiveness of omega-3 fish oil supplements in combating colorectal cancer. The study highlights that these supplements, specifically omega-3 fatty acids like EPA and DHA, are beneficial in reducing cancer risk only when the enzyme ALOX15 is present. This enzyme plays a pivotal role in metabolizing these fatty acids, enabling their anti-cancer properties. Without ALOX15, the anticipated health benefits of omega-3s could be significantly diminished, and in some instances, might even prove counterproductive. The research suggests that the absence of this enzyme could lead to an imbalance, potentially exacerbating certain health issues rather than alleviating them. This finding underscores the complexity of dietary supplements and the importance of understanding individual biological differences. The implications of this discovery are vast, indicating a need for personalized nutrition strategies. As researchers delve deeper into the interactions between dietary components and genetic factors, the potential for tailored health recommendations grows. This study serves as a reminder that while omega-3 supplements are widely consumed for their health benefits, their impact can vary greatly depending on individual enzymatic profiles.

— Authored by Next24 Live